Skip to content

Clinical trials

Thromboembolism trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Thromboembolism Country / region: United States Clear all

78 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20011
20021
20032
20043
20053
20066
20074
20084
20091
20103
20114
20122
20131
20146
20152
20165
20173
20181
20193
20203
20211
20222
20236
20242
20253
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed56
Terminated8
Recruiting5
Unknown status4
Active, not recruiting3
Enrolling by invitation1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer5
Boehringer Ingelheim4
Inari Medical3
ARCA Biopharma, Inc.2
Brigham and Women's Hospital2
Bristol-Myers Squibb2
Daiichi Sankyo2
Imperative Care, Inc.2
Janssen Research & Development, LLC2
Mayo Clinic2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Thromboembolism78
Thrombosis22
Pulmonary Embolism17
Venous Thromboembolism12
Venous Thrombosis10
Embolism8
Stroke8
Atrial Fibrillation5
Cardiovascular Diseases5
Myocardial Infarction4

Trials

Showing 1 to 25 of 78. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.